We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Cabut Coordinates Metabolism and Clock in Response to Nutrient Sensing

By LabMedica International staff writers
Posted on 01 Jun 2015
Print article
Caption: Using a Drosophila fruit fly model to study sugar sensing, researchers have discovered that the transcription factor “cabut” (cbt) represses accumulation of several metabolic targets and provides a regulatory link between nutrient sensing and the circadian clock (Photo courtesy of Bartok O, Mari Teesalu, et al. 2015, and EMBO Journal).
Caption: Using a Drosophila fruit fly model to study sugar sensing, researchers have discovered that the transcription factor “cabut” (cbt) represses accumulation of several metabolic targets and provides a regulatory link between nutrient sensing and the circadian clock (Photo courtesy of Bartok O, Mari Teesalu, et al. 2015, and EMBO Journal).
Using a Drosophila fruit fly model to study sugar sensing, researchers have discovered that the transcription factor and developmental growth regulator, cabut, coordinates energy metabolism as well as the circadian clock in response to sugar sensing.

Sugar feeding in flies leads to a sugar-sensing pathway that along one branch induces expression of specific genes, but also triggers a repression branch of the sugar-sensing transcriptional network via cabut (CBT, encoded by cbt) in Drosophila melanogaster. However, mechanisms of transcriptional repression upon sugar sensing have remained elusive. In the new collaborative study of response to sugar, a team of researchers, led by Prof. Ville Hietakangas of the University of Helsinki (Helsinki, Finland) and Prof. Sebastian Kadener of the Hebrew University of Jerusalem (Jerusalem, Israel), found that induction of cbt represses accumulation of several metabolic targets and provides a regulatory link between nutrient sensing and the circadian clock.

Among the metabolic targets, CBT was found to repress the expression of both isoforms of the enzyme phosphoenolpyruvate carboxykinase (PEPCK). They also found that upon sugar feeding cbt is rapidly induced through direct regulation by the Mondo‐Mlx transcription factor complex. Deregulation of pepck1 in mlx mutants was found to underly the imbalance of glycerol and glucose metabolism as well as the developmental lethality of these mutants.

In addition to a subset of metabolic genes per se, the researchers found that CBT also targets a subset of genes regulated by the circadian clock and represses the cycling of metabolic target genes of this clock. They observed that perturbation of CBT levels even led to deregulation of the circadian transcriptome and circadian behavioral patterns.

The study, by Bartok O, Mari Teesalu, et al, was published online April 27, 2015, in EMBO Journal.

Related Links:

University of Helsinki
Hebrew University of Jerusalem


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.